Website Information
    Web Site Information :.   Site Info    Whois    Traceroute    RBL Check  

Enter Web Site URL Address:
 

prostate-cancer-institute.org: Prostate Cancer Treatment | Latest Advances
 
 
 

Prostate Cancer Treatment | Latest Advances

Tags: prostate, cancer, treatment, advances, latest, institute, health, verify, click, website, net, foundation, certified, glossary, home, partner, physician, options, support, waiting, watchful, information, treatments, brachytherapy, therapy, hormonal, getting, giving, evaluation, ebrt, self, prostatectomy, site, contact, disclaimer, privacy, standard, honcode, partners, advisory,

Prostate-cancer-institute.org

Content Revalency: Title: 66.67%   Description: 0.00%   Keywords: 0.00%  |  Document size: 32,448 bytes
Quantcast rank: #109,437   More info: Whois - Trace Route - RBL Check
 
PROSTATE-CANCER-INSTITUTE.ORG - Site Location
Country/Flag US United States
City/Region/Zip Code Balsam Lake, WI, 54810
Organization Vector Internet Services
Internet Service Provider Vector Internet Services
 
PROSTATE-CANCER-INSTITUTE.ORG - Domain Information
Domain PROSTATE-CANCER-INSTITUTE.ORG   [ Traceroute  RBL/DNSBL lookup ]
Registrar MarkMonitor Inc.
Whois server whois.pir.org
Created --
Updated --
Expires --
Time Left 0 days 0 hours 0 minutes
Status ok https://icann.org/epp#ok
DNS servers NS2.MARKMONITOR.COM   64.124.69.52
NS1.MARKMONITOR.COM   64.124.69.50
NS7.MARKMONITOR.COM   64.124.69.51
NS6.MARKMONITOR.COM   202.167.230.241
NS5.MARKMONITOR.COM   202.167.230.240
NS4.MARKMONITOR.COM   217.68.151.241
NS3.MARKMONITOR.COM   217.68.151.240
 
PROSTATE-CANCER-INSTITUTE.ORG - DNS Information
IP Address 209.98.51.113 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns.visi.com   209.98.98.1
www.threewire.com   76.223.34.124
Mail Exchange spam.threewire.com  
 
Site Response Header
Response HTTP/1.1 302 Found
Server Lotus-Domino
Date Sat, 16 Apr 2011 01:31:35 GMT
Content-Type text/html


  IP Index    TLD Index    Domain Index    Site Index New   Copyright © 2025 Cybernet Quest.